SCHEMBL5086449

SCHEMBL5086449

NCC1CCC(n2nc(-c3cc4nc(-c5ccccc5)ccc4cc3Cl)c3cncnc32)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.36
CYP2C19 P33261 5/20 0.36
ALDH1A1 P00352 3/20 0.36
ALOX15 P16050 2/20 0.36
TSHR P16473 2/20 0.36
HPGD P15428 1/20 0.36
PIK3CD O00329 3/20 0.35
PIK3CA P42336 3/20 0.35
PIK3CB P42338 3/20 0.35
PIK3CG P48736 3/20 0.35
PRKDC P78527 3/20 0.35
EGFR P00533 3/20 0.35
ABL1 P00519 2/20 0.35
HCK P08631 2/20 0.35
SRC P12931 2/20 0.35
KDR P35968 2/20 0.35
MTOR P42345 2/20 0.35
EPHB4 P54760 2/20 0.35
CYP3A4 P08684 4/20 0.35
CYP2C9 P11712 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138987 0.87 CYP1A2 (0.39) CYP1A2CYP2C19ALDH1A1ALOX15TSHR
SCHEMBL5137414 0.87 IGF1R (0.41) CYP1A2CYP2C19ALDH1A1ALOX15TSHR
SCHEMBL400250 0.86 PIK3CD (0.48) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL5084774 0.85 SRC (0.37) CYP1A2CYP2C19ALDH1A1ALOX15TSHR
SCHEMBL5083760 0.81 IGF1R (0.44) CYP1A2CYP2C19ALDH1A1ALOX15TSHR
SCHEMBL399448 0.76 KDR (0.46) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL396337 0.76 PIK3CD (0.56) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL397796 0.75 SRC (0.55) CYP1A2CYP2C19ALDH1A1HPGDEGFR
SCHEMBL5138756 0.75 IGF1R (0.44) EGFRKDRCYP3A4IGF1R
SCHEMBL401547 0.74 PIK3CD (0.59) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP disclosed
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO disclosed